MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zwart, R.
Right arrow Articles by Vijverberg, H. P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zwart, R.
Right arrow Articles by Vijverberg, H. P. M.

Vol. 54, Issue 6, 1124-1131, December 1998

Four Pharmacologically Distinct Subtypes of alpha 4beta 2 Nicotinic Acetylcholine Receptor Expressed in Xenopus laevis Oocytes

Ruud Zwart and Henk P. M. Vijverberg

Research Institute of Toxicology, Utrecht University, Utrecht, The Netherlands

    Summary
Top
Summary
Introduction
Procedures
Results
Discussion
References

Nicotinic receptors generally are presumed to consist of two alpha  and three non-alpha subunits. We varied the relative levels of expression of the neuronal nicotinic alpha 4 and beta 2 receptor subunits in Xenopus laevis oocytes by nuclear injection of cDNAs coding for these subunits in alpha :beta ratios of 9:1, 1:1, and 1:9. The sensitivities of the receptors to acetylcholine and d-tubocurarine were investigated in voltage-clamp experiments. For receptors expressed at the 9:1 and 1:1 alpha :beta ratios, the EC50 value of acetylcholine is ~60 µM. For the majority of the receptors expressed at the 1:9 alpha :beta ratio, the sensitivity to acetylcholine is enhanced 30-fold. No evidence for more than one type of acetylcholine binding site in a single receptor is obtained. The sensitivity to d-tubocurarine decreases with decreasing alpha :beta ratio. IC50 values of d-tubocurarine are 0.2, 0.5, and 2 µM for the 9:1, 1:1, and 1:9 alpha :beta ratios, respectively. At the 1:9 alpha :beta ratio, additional receptors with an IC50 value of 163 µM d-tubocurarine are expressed. At least two components with distinct sensitivities to d-tubocurarine are required to account for the shift in IC50. The combined agonist and antagonist effects reveal four distinct subtypes of alpha 4beta 2 nicotinic receptors. The results imply that the subunit stoichiometry of heteromeric alpha 4beta 2 acetylcholine receptors is not restricted to 2alpha :3beta .

    Introduction
Top
Summary
Introduction
Procedures
Results
Discussion
References

Neuronal nAChRs are ligand-gated ion channels present throughout the central and peripheral nervous systems. Multiple neuronal nAChR subunits (alpha 2-9 and beta 2-4) have been identified. These subunits combine in various compositions to form pentameric receptors with different functional and pharmacological characteristics (reviewed in McGehee and Role, 1995).

The alpha 4 and beta 2 nAChR subunits are expressed abundantly in brain (Wada et al., 1989), and the most common nAChR in the brain is composed of these two subunits (Whiting et al., 1990; Flores et al., 1992). The subunit stoichiometry of alpha 4beta 2 nAChRs expressed in Xenopus laevis oocytes has been deduced to be alpha 4:beta 2 = 2:3 (Anand et al., 1991; Cooper et al., 1991), and the subunits are assumed to be arranged around the central ion channel pore in the order beta alpha beta alpha beta (Anand et al., 1991). Patch-clamp recording from oocytes expressing pairs of alpha  and beta  nAChR subunits revealed ACh-gated single channels with distinct conductances (Papke et al., 1989; Papke and Heinemann, 1991; Charnet et al., 1992; Kuryatov et al., 1997). The frequency of occurrence of the different single-channel conductance states depends on the alpha :beta ratio of the mRNA mixture injected into the oocyte, indicating that receptors with different subunit stoichiometry are expressed (Papke et al., 1989).

The agonist binding sites of heteropentameric neuronal nAChRs generally are supposed to be located at the two alpha beta subunit interfaces (reviewed in Bertrand and Changeux, 1995). Functional nAChRs with distinct subunit stoichiometries might differ with respect to the number and properties of agonist binding sites. We investigated the functional properties of the agonist binding sites in X. laevis oocytes expressing different levels of alpha 4 and beta 2 nAChR subunits. The results on concentration-dependent effects of the agonist ACh and of d-TC, a competitive antagonist of alpha 4beta 2 nAChRs (Bertrand et al., 1990), demonstrate four distinct subtypes of alpha 4beta 2 nAChRs.

    Experimental Procedures
Top
Summary
Introduction
Procedures
Results
Discussion
References

Materials. X. laevis were bred and kept in the Hubrecht Laboratory (Utrecht, The Netherlands) or were bought from Nasco (Fort Atkinson, WI) and kept in our own laboratory. Neomycin was obtained from Sigma Chemical (St. Louis, MO). d-TC was from Fluka (Buchs, Switzerland). All other materials used came from sources identical to those described previously (Zwart and Vijverberg, 1997).

Receptor expression. Oocytes were prepared, injected, and incubated in Barth's solution containing 5 mg/liter of neomycin at 19° for 3-7 days as described previously (Zwart et al., 1995; Zwart and Vijverberg, 1997). Plasmids coding for alpha 4 and beta 2 subunits of neuronal nAChRs were dissolved in distilled water at the approximately equal concentrations of 152 ± 15 and 136 ± 12 µg/ml (mean ± standard deviation of triplicate spectrophotometric determinations), respectively. Unless noted otherwise, mixtures of these solutions at 1:9, 1:1, and 9:1 ratios were coinjected at 18.4 nl/oocyte.

Electrophysiology and data analysis. Oocytes were placed in a silicon rubber tube (diameter, 3 mm), penetrated by two microelectrodes, and voltage clamped at -80 mV. ACh and d-TC, dissolved in external solution, were applied by perfusion of the tube at a rate of ~20 ml/min. The external saline contained 115 mM NaCl, 2.5 mM KCl, 1 mM CaCl2, and 10 mM HEPES, pH 7.2, with NaOH. Voltage-clamp equipment, experimental protocols, and data acquisition were exactly as described previously (Zwart and Vijverberg, 1997). All amplitudes of ACh-induced ion currents were normalized to the amplitude of alternately evoked control responses to a near-maximum effective concentration of ACh to adjust for small variations in response amplitude over time. Data are expressed as mean ± standard deviation of number of oocytes. ANOVA was performed using Microsoft Excel. Results were compared using a two-tailed Student's t test. Concentration-effect curves were fitted, using Jandel SigmaPlot software, to data obtained in separate experiments, and mean ± standard deviation values of estimated parameters were calculated for three oocytes. Curves drawn in the figures were generated using the mean values of the estimated parameters. Agonist data were fitted according to the equations i/imax = Emax/[1 + (EC50/[ACh])nH] and i/imax = Emaxa/(1 + EC50a/[ACh]) + Emaxb/(1 + EC50b/[ACh]) for one- and two-component activation curves, respectively. Antagonist data were fitted according to the equations: i/imax = 1/[1 + ([dTC]/IC50)nH] and i/imax = Em/[1 + ([dTC]/IC50a)nHa) + (1 - Em)/[1 + ([dTC]/IC50b)nHb] for one- and two-component inhibition curves, respectively. In these equations, [ACh] and [dTC] are the concentrations of ACh and d-TC, respectively; nH is the Hill coefficient; and i/imax is the normalized current amplitude. Goodness-of-fit was judged by analysis of the residuals (run test).

    Results
Top
Summary
Introduction
Procedures
Results
Discussion
References

Effects of alpha 4:beta 2 ratio on ion current amplitude. Superfusion of voltage-clamped oocytes, expressing alpha 4beta 2 nAChRs after the injection of alpha 4 and beta 2 subunit cDNAs in the alpha :beta ratios 1:9, 1:1, and 9:1, with 300 µM ACh results in ligand-gated ion currents. The effect of subunit ratio on response amplitude was investigated in the same batch of oocytes because expression levels vary between batches. The amplitude of the inward current induced by the near-maximal effective concentration of 300 µM ACh at the holding potential of -80 mV depends on the alpha 4:beta 2 subunit cDNA ratio injected into the oocytes (Fig. 1). The largest inward currents are observed in oocytes injected with alpha 4 and beta 2 subunit cDNAs in the 1:1 ratio. At both the 1:9 and 9:1 alpha :beta ratios, amplitudes of inward currents evoked by 300 µM ACh are reduced significantly (t test; p < 0.001). Some oocytes (9 of 54) that did not respond to ACh at all, most likely because the cDNA was not properly injected into the nucleus, were excluded from the analysis. The results show that, after injection of the alpha 4 and beta 2 subunit cDNAs in extreme ratios, while maintaining the total cDNA injected approximately constant, inward current amplitudes are reduced. This indicates that after injection of cDNAs in the alpha :beta ratios of 1:9 and 9:1, response amplitude is limited by the availability of alpha  and beta  subunits, respectively. After injection of the same total amounts of either cDNA encoding the alpha 4 subunit only or cDNA encoding the beta 2 subunit only, oocytes did not respond to 300 µM ACh (results not shown). This demonstrates that alpha 4 and beta 2 subunits do not form functional homopentameric nAChRs. The absence of ACh-induced inward current also shows that alpha 4 and beta 2 do not form functional heteromeric nAChRs with native nAChR subunits that possibly are present in X. laevis oocytes (Buller and White, 1990).


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 1.   Peak inward current amplitudes evoked by superfusion with 300 µM ACh in X. laevis oocytes expressing alpha 4beta 2 nAChRs. Oocytes from a single batch were injected with approximately equal amounts of cDNAs encoding alpha 4 and beta 2 nAChR subunits in the ratios indicated. Bars, mean ± standard deviation values of peak amplitudes from the number of oocytes indicated (between brackets). Peak amplitudes obtained for the 1:9 and 9:1 alpha :beta ratios are significantly reduced compared with those obtained for the 1:1 alpha :beta ratio (t test; p < 0.001).

Effects of alpha 4:beta 2 ratio on the agonist concentration-effect curve. Agonist concentration-effect curves were obtained from oocytes expressing alpha 4beta 2 nAChRs after the injection of subunit cDNAs in the alpha :beta ratios of 1:9, 1:1, and 9:1. Examples of ACh-induced ion currents are shown in Fig. 2A for the different subunit cDNA ratios tested.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 2.   Concentration-dependent effects of ACh on alpha 4beta 2 nAChRs expressed in X. laevis oocytes after injection of cDNAs in the alpha :beta ratios indicated. a, Inward currents evoked by 10-sec periods of superfusion with external saline containing ACh at the concentrations indicated for three oocytes at the 1:1 (bullet ), 9:1 (open circle ), and 1:9 () alpha :beta ratios. Calibration bars, 4.5 µA (1:1) and 350 nA (9:1 and 1:9). b, Dependence of inward current amplitude, normalized to the amplitude of control responses induced by 1 mM ACh, on the concentration of ACh. Values are mean ± standard deviation obtained from three oocytes. The data obtained for the 1:1 and 9:1 alpha :beta ratios were fitted adequately by one-component concentration-effect curves (drawn lines). Data obtained at concentrations of >300 µM ACh, which induced ion channel block, are not included in the fit. The data obtained for the 1:9 alpha :beta ratio could not be fitted by a one-component concentration-effect curve. The two-component curve drawn was fitted to all data obtained at concentrations of <= 300 µM ACh with slope factors set to 1. The concentration-effect curve describing the component more sensitive to ACh, fitted separately to the data obtained at <= 30 µM ACh, is also drawn. The estimated parameters of the fitted curves are presented in Table 1.

From Fig. 2A, it is apparent that inward currents evoked by high concentrations of ACh show an acceleration of inward current decay. In addition, a "tail" inward current is observed on removal of the agonist. These effects are commonly attributed to the onset and reversal of ion channel block by high concentrations of ACh (Colquhoun and Ogden, 1988; Oortgiesen and Vijverberg, 1989). For the different alpha :beta ratios, inward current decay in the absence of overt ion channel block (i.e., for responses evoked by superfusion with 300 µM ACh) was quantified by dividing the inward current at the end of ACh application (t = 10 sec) by the peak inward current. The inward current decayed to 61 ± 16% (5 oocytes) of the peak value for the 1:1 alpha :beta ratio, to 51 ± 11% (7 oocytes) for the 9:1 alpha :beta ratio, and to 82 ± 4% (14 oocytes) for the 1:9 alpha :beta ratio. The degree of inward current decay at the 1:9 ratio differs significantly from that at the 1:1 and 9:1 alpha :beta ratios (t test; p < 0.05).

For each of the alpha :beta subunit cDNA ratios investigated, the amplitudes of peak inward current evoked by superfusion of 0.1 µM to 10 mM ACh were normalized to those of 1 mM ACh-induced inward currents in three oocytes. Two-way ANOVA of the results obtained with ACh at concentrations of <= 1 mM showed that the data for the 1:1 and 9:1 alpha :beta ratios cannot be distinguished statistically (F1,28 = 0.1441, p = 0.71) and that both sets of data differ statistically from the data obtained for the 1:9 ratio (p < 0.001). Concentration-effect curves of ACh were fitted for each alpha :beta ratio. The data of the 1:1 and 9:1 alpha :beta ratios are closely approximated by one-component sigmoidal curves (Fig. 2B). In all cases, data measured at the higher ACh concentrations, which induce ion channel block, were excluded from the curve-fitting procedure. For the 1:9 alpha :beta ratio, the concentration-effect curve shows a striking shift toward lower agonist concentrations, and the slope of the data is markedly reduced. Together with the inflection point in the data observed between 10 and 100 µM ACh (Fig. 2B), this suggests the presence of two components with distinct sensitivities to the agonist. A one-component concentration-effect curve did not fit the data adequately as indicated by analysis of the residuals (run test; p < 0.05). The data obtained for concentrations of <1 mM ACh could be fitted by a two-component concentration-effect curve only with fixed values of the slope factors. EC50 values of 1.74 and 144 µM ACh and Emax values of 85% and 43%, respectively, were obtained when the slope factors were set to 1. Due to the small number of data available for curve fitting at high agonist concentrations, reliable estimates for the less-sensitive component cannot be obtained. A one-component concentration-effect curve fitted to the data obtained with ACh at concentrations of <= 30 µM yielded EC50, nH, and Emax values of 1.84 µM ACh, 1.05, and 89.3%, respectively (Table 1). The two concentration-effect curves both seem to fit the more-sensitive component accurately (Fig. 2B). The large Emax value of the more-sensitive component of the concentration-effect curve indicates that the majority of nAChRs expressed at the 1:9 alpha :beta cDNA ratio are highly sensitive to ACh. Oocytes injected with cDNAs encoding alpha 3 and beta 2, or alpha 4 and beta 4, in a 1:9 alpha :beta ratio did not show enhanced sensitivity to ACh compared with oocytes injected with these subunit cDNAs in a 1:1 alpha :beta ratio (not shown).

                              
View this table:
[in this window]
[in a new window]
 
TABLE 1
Effects of ACh on alpha 4beta 2 nAChRs expressed in Xenopus oocytes injected with cDNAs encoding alpha  and beta  subunits in the ratios indicated

For each experimental condition, three concentration-effect curves, each obtained from a different oocyte, were fitted, and the values represent mean ± standard deviation of the estimated parameters.

From the ANOVA of the data and from the EC50 values estimated from the concentration-effect curves (Table 1), it is concluded that depending on the ratio of alpha 4 and beta 2 subunit cDNAs injected, two distinct types of functional nAChRs are expressed in oocytes with ~30-fold difference in sensitivity to ACh.

Effects of alpha 4:beta 2 ratio on the antagonist concentration-effect curve. Concentration-effect curves for the competitive nAChR antagonist d-TC also were obtained from oocytes expressing alpha 4beta 2 nAChRs after the injection of subunit cDNAs in the alpha :beta ratios of 1:9, 1:1, and 9:1. Examples of ion currents evoked by superfusion of 300 µM ACh in the absence and the presence of various concentrations of d-TC are shown in Fig. 3A for the different subunit cDNA ratios tested. d-TC was superfused >= 4 min before an ACh-induced current was recorded in the presence of d-TC. For three oocytes of each alpha :beta subunit cDNA ratio tested, peak inward current amplitudes were normalized to those of control inward currents evoked by 300 µM ACh in the same oocyte. The normalized data are plotted against d-TC concentration in Fig. 3A. ANOVA of the inhibitory effects of d-TC showed that the data for the different subunit cDNA ratios all are statistically different at the p < 0.001 level. For the 9:1 and 1:1 alpha :beta subunit cDNA ratios, data could be fitted by a one-component concentration-effect curve. However, for the 1:9 ratio, the concentration dependence of inhibition by d-TC seemed to be biphasic, and fit was significantly improved by fitting a sum of two concentration-effect curves to the data (Fig. 3A). Estimated values of the parameters of the fitted concentration-effect curves are presented in Table 2. The inhibitory effects of d-TC on alpha 4beta 2 nAChRs at the 1:1 alpha :beta ratio also were investigated at a holding potential of -40 mV (result not shown). The IC50 value for d-TC of 0.91 ± 0.48 µM (three oocytes) at -40 mV could not be distinguished from that obtained at the holding potential of -80 mV. Thus, it seems that voltage-dependent ion channel block, observed previously for muscle-type nAChRs at high concentrations of d-TC (Colquhoun et al., 1979), does not strongly contribute to the inhibitory effects of d-TC observed at concentrations of <= 10 µM.


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 3.   Concentration-dependent effects of d-TC on alpha 4beta 2 nAChRs expressed in X. laevis oocytes after injection of cDNAs in the alpha :beta ratios indicated. a, Top, inward currents evoked by 10-sec periods of superfusion with external saline containing 300 µM ACh in the presence of d-TC at the concentrations indicated for three oocytes at the 1:1 (bullet ), 9:1 (open circle ), and 1:9 () alpha :beta ratios. Bottom, dependence of inward current amplitude, normalized to the amplitude of control responses induced by 300 µM ACh, on the concentration of d-TC. Values are mean ± standard deviation obtained from three oocytes. Drawn lines, mean of one-component agonist concentration-effect curves fitted to the data obtained for the 1:1 and 9:1 alpha :beta ratios and of two-component concentration-effect curves fitted to the data obtained for the 1:9 alpha :beta ratio to account for a second component of inhibition. The estimated parameters of the fitted curves are presented in Table 2. Calibrations bars, 2 µA (1:1), 500 nA (9:1), and 100 nA (1:9). b,Inhibition of inward currents evoked by 10-sec periods of superfusion with external saline containing 10 µM ACh in the presence of d-TC at the concentrations indicated. The low concentration of ACh selectively activates the more-sensitive alpha 4beta 2 nAChRs expressed at the 1:9 alpha :beta ratio (see Fig. 2B). Calibration bar, 50 nA. Bottom, concentration-dependent inhibition of inward current amplitude by d-TC (), which is fitted by a monophasic inhibition curve (drawn line). The biphasic inhibition curve obtained for the inhibition of 300 µM ACh-induced inward current is drawn for comparison. Dashed inhibition curves (A and B), results of fitting a model assuming two sites for the inhibition by d-TC contributing differentially to the curves obtained at the different alpha :beta ratios (see Discussion).

                              
View this table:
[in this window]
[in a new window]
 
TABLE 2
Inhibitory effects of d-TC on alpha 4beta 2 nAChRs expressed in Xenopus oocytes injected with cDNAs encoding alpha  and beta  subunits in the ratios indicated

Responses were evoked by superfusion with 300 µM ACh. For each experimental condition, three concentration-effect curves, each obtained from a different oocyte, were fitted, and the values represent mean ± standard deviation of the estimated parameters.

Additional experiments were performed to investigate the relation between the two components of inhibition by d-TC (Fig. 3A) and the two components of ACh sensitivity (Fig. 2B) for the 1:9 alpha :beta ratio. Inward currents were evoked by superfusion with 10 µM ACh to selectively activate the more sensitive nAChRs. The data on the inhibition of 10 µM ACh-induced inward current by d-TC are well fitted by a one-component concentration-effect curve (Fig. 3B) with an IC50 value (see Table 2) that cannot be distinguished from that of the more-sensitive component of inhibition of 300 µM ACh-evoked responses (t test; p = 0.11). Comparison of the inhibition curves of d-TC obtained with 10 and 300 µM ACh (Fig. 3B) shows that at the 1:9 alpha :beta ratio, two subtypes of nAChRs are expressed: one subtype more sensitive to ACh and one less sensitive to d-TC than the receptors expressed at the other alpha :beta ratios, and a second subtype with low sensitivity to ACh and very low sensitivity to d-TC. The IC50 of d-TC shifts toward higher concentrations with decreasing alpha :beta ratio (ANOVA; p values < 0.001), and the IC50 values of d-TC obtained at the different alpha :beta ratios differ statistically (t test; p values < 0.01; Table 2).

To investigate the mechanism of inhibition of the component of nAChR-mediated ion current with a very low sensitivity to d-TC observed at the 1:9 alpha :beta ratio, oocytes were continuously superfused with 30 µM d-TC to eliminate the more-sensitive component (see Fig. 3A). Inward currents evoked by superfusion with 100 µM ACh in the presence of 30 µM d-TC, which represent the less-sensitive component, and after preexposure to 330 µM d-TC for 4 min were recorded to establish low affinity inhibition. Inward currents evoked at a holding potential of -60 mV were reduced by 81.7 ± 1.6% (three oocytes) by increasing the concentration of d-TC from 30 to 330 µM (Fig. 4A). In the same oocytes, low affinity inhibition at a holding potential of -100 mV (Fig. 4B) amounted to 86.9 ± 2.4%. The small difference is statistically significant (t test; p < 0.05), indicating some voltage dependence of the inhibitory effect. Inward currents evoked by coapplication of 100 µM ACh and 330 µM d-TC show a reduction in the peak amplitude and a rapid further onset of inhibition by d-TC during the response (Fig. 4C). At the steady level of inhibition, which was achieved within a few seconds, the amount of reduction of the inward current is the same as that obtained with preexposure to d-TC. The apparent absence of kinetic effects after preexposure to d-TC (Fig. 4, A and B) and the absence of a pronounced tail current on removal of the high concentration of d-TC (Fig. 4C) indicate that ion channel opening is not required for the inhibitory effect. Together with the weak voltage dependence of inhibition, these results indicate that even at high concentrations, d-TC does not cause significant ion channel block.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 4.   Ion currents with very low sensitivity to d-TC in oocytes injected with alpha 4 and beta 2 cDNAs at the 1:9 alpha :beta ratio and the inhibitory effect of a high concentration of d-TC. Oocytes were superfused continuously with 30 µM d-TC to inhibit the d-TC-sensitive component of ACh-induced ion current (see Fig. 3A). a, Inward currents evoked with 100 µM ACh before and 4 min after raising the d-TC concentration to 330 µM at the holding potential of -60 mV. b, Inward currents from the same oocyte demonstrating the inhibitory effect of d-TC at the holding potential of -100 mV. c, Inhibitory effect of coapplication of 100 µM ACh and 330 µM d-TC illustrating a reduced peak inward current amplitude and accelerated inward current decay. Horizontal calibration bar, 10 sec. Vertical calibration bar, 100 nA (A and C) and 200 nA (B).

Effects of nAChR expression level on agonist and antagonist sensitivities. Because it cannot be excluded that nAChR expression level by itself affects agonist and antagonist sensitivity, experiments were performed on oocytes injected with diluted 1:1 alpha :beta cDNA solution at constant injection volume. In oocytes injected with a 10-fold diluted cDNA solution, superfusion with 1 mM ACh did not evoke detectable (>5 nA) inward currents (10 oocytes). This indicates that nAChR expression is greatly reduced, consistent with previous results on the expression level of chick alpha 4beta 2 nAChRs in oocytes (Bertrand et al., 1991). After the injection with a 4-fold diluted cDNA solution, ACh-induced ion currents were evoked, which were smaller than those obtained before but had a similar shape (Fig. 5A). The inward current decay at the end of ACh application amounted to 48 ± 15% (five oocytes) of the peak current. This cannot be distinguished from the degree of decay at the higher expression level (t test; p = 0.24) but differs from the degree of inward current decay obtained for the 1:9 alpha :beta ratio (p < 0.01). Agonist and antagonist sensitivities were determined from six oocytes with a maximal peak inward current amplitude of 398 ± 82 nA (i.e., in the same range as with the 1:9 and 9:1 alpha :beta ratios). The results obtained with ACh at concentrations of <= 1 mM from oocytes with high and low level nAChR expression at the 1:1 alpha :beta ratio are not identical (two-way ANOVA; F1,28 = 7.556, p = 0.01). Although the fitted concentration-effect curve of ACh (Fig. 5A, Table 1) shows a small shift toward higher concentrations, the EC50 and nH values cannot be distinguished from those obtained for the higher expression level (t test; p > 0.08). The concentration-effect curve of d-TC at the low expression level (Fig. 5B, Table 2) cannot be distinguished statistically from that obtained with the high expression level at the 1:1 alpha :beta ratio (two-way ANOVA; F1,20 = 2.290, p = 0.15). However, this curve differs from the inhibition curves obtained for the 9:1 and 1:9 alpha :beta ratios (two-way ANOVA; p < 0.001). Further statistical analysis showed that the expression level does not influence the IC50 value of d-TC (t-test; p = 0.33) and that regardless of expression level, distinct IC50 values are obtained for the different subunit ratios (t test; p values < 0.01). From the combined results, it is concluded that reducing the nAChR expression level causes only a small decrease in ACh sensitivity, which is opposite the 30-fold increase in sensitivity observed at the 1:9 alpha :beta ratio.


View larger version (10K):
[in this window]
[in a new window]
 
Fig. 5.   Agonist and antagonist sensitivities of alpha 4beta 2 nAChRs expressed in oocytes injected with 4-fold diluted 1:1 alpha :beta cDNA solution. a, Inward currents evoked by 10-sec periods of superfusion with external saline containing ACh at the concentrations indicated (calibration bar, 200 nA). Bottom, mean ± standard deviation of peak inward current amplitudes normalized to that of 1 mM ACh-evoked inward currents from three oocytes. The data were fitted by a one-component concentration-effect curve (drawn line). For comparison, the concentration-effect curve obtained for alpha 4beta 2 nAChRs at the higher expression level with the 1:1 alpha :beta ratio (Fig. 2A) is drawn (dashed line). Data obtained at 1 mM ACh, which induced ion channel block, are not included in the fit. b, Inhibition of 300 µM ACh-induced inward current by d-TC at the concentrations indicated (calibration bar, 500 nA). Bottom, mean ± standard deviation (three oocytes) of peak inward current amplitudes normalized to that of 300 µM ACh-evoked control responses. The two data points without error bars, from one oocyte. The data were fitted by a one-component concentration-effect curve (drawn line). The estimated parameters of the curves fitted to the data in A and B are presented in Tables 1 and 2, respectively.

    Discussion
Top
Summary
Introduction
Procedures
Results
Discussion
References

Differences in agonist and antagonist sensitivities of receptors expressed in oocytes after injection of cDNAs coding for the alpha 4 and beta 2 subunits at 1:9, 1:1, and 9:1 ratios demonstrate heterogeneity of alpha 4beta 2 nAChRs. The results show that combinations of alpha 4 and beta 2 subunits form four pharmacologically distinct subtypes of heteromeric nAChRs. Two subtypes of nAChRs, which are distinguished for the 1:1 and 9:1 alpha :beta ratios, have similar low sensitivities to ACh (EC50 approx  60 µM) but distinct sensitivities to d-TC (IC50 = 0.20 and 0.53 µM, respectively). Two additional, distinct subtypes of nAChRs are formed at the 1:9 alpha :beta ratio: one subtype with markedly enhanced sensitivity to ACh (EC50 = 1.8 µM) and decreased sensitivity to d-TC (IC50 = 2.04 µM), and a second subtype with low sensitivity to ACh and very low sensitivity to d-TC (IC50 = 163 µM). Heterogeneity of neuronal nAChRs has been suggested before from the observation that the occurrence of distinct single-channel conductances in oocytes expressing neuronal-type nAChRs depends on alpha :beta ratio (Papke et al., 1989).

The effects of varying alpha :beta ratio on the properties of nAChRs were investigated in oocytes injected with approximately equal total amounts of cDNA (2.5-2.8 ng/oocyte). The reduced response amplitudes at the 1:9 and 9:1 ratios indicate that the availability of alpha  and beta  subunits limits functional receptor expression at these cDNA ratios (Fig. 1). A comparison of the properties of nAChRs expressed at a reduced level for the 1:1 alpha :beta ratio (Fig. 5) with those of nAChRs expressed at the 1:9 and 9:1 ratios (Figs. 2, 3) demonstrates that the 30-fold difference in sensitivity to ACh, the shift in sensitivity to d-TC, and the differences in the degree of inward current decay are due to changes in subunit ratio and not to differences in expression level.

The properties of ligand-gated ion channels depend on subunit composition. Combining alpha 4 and beta 2 subunits into a pentameric nAChR protein theoretically can yield eight distinct subtypes of the alpha 4beta 2 nAChR. The two homopentameric alpha 4 and beta 2 nAChRs are not expressed or are not functional. Six heteropentameric subunit assemblies remain: four alpha :beta subunit stoichiometries (1:4, 2:3, 3:2, and 4:1) and two alternative subunit arrangements for the 2:3 and the 3:2 stoichiometries (Fig. 6). Of these six, at least four have been demonstrated to form pharmacologically distinct, functional nAChRs. This implies that functional alpha 4beta 2 nAChRs are formed with other than the 2:3 alpha :beta subunit stoichiometry.


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 6.   Schematic representation of the six possible arrangements of alpha  and beta  subunits within heteropentameric nAChRs. Note the two alternative subunit arrangements for the 2:3 and 3:2 alpha :beta subunit stoichiometries.

Functional heteropentameric neuronal nAChRs presumably contain two binding sites for ACh located at the alpha beta interfaces (Luetje and Patrick, 1991; Bertrand and Changeux, 1995). However, only two of all possible subunit assemblies contain two alpha beta interfaces (Fig. 6). The conclusion that four distinct types of alpha 4beta 2 nAChRs are formed implies that agonist binding at one or more of the beta alpha , beta beta , or alpha alpha subunit interfaces may be involved in ion channel activation or that binding of a single agonist molecule is sufficient to activate alpha 4beta 2 nAChRs. The latter would be consistent with the results because the slopes of the concentration-effect curves of ACh all are close to 1 (Table 1). Shallow slopes of the concentration-effect curve of ACh on alpha 4beta 2 nAChRs generally are reported: in oocyte studies, 0.81 for rat alpha 4beta 2 (Stafford et al., 1994), 1.5 for chick alpha 4beta 2 (Bertrand et al., 1990), and 1.02 for human alpha 4beta 2 (Chavez-Noriega et al., 1997), and in human embryonic kidney 293 cells, 1.2 for human alpha 4beta 2 (Buisson and Bertrand, 1998). In alpha 7 nAChRs, alpha alpha interfaces contribute to ligand binding. This homopentameric nAChR seems to contain five binding sites for the competitive antagonist methyllycaconitine (Palma et al., 1996). The alpha 7 subunit contains the principal component (loops A-C) as well as the highly conserved residue Trp54, which constitutes part of a complementary component of the proposed agonist binding site. These two components of the agonist binding site in alpha 7 are thought to be equivalent to those contained by the muscle-type alpha 1 and the gamma  and delta  nAChR subunits, respectively. The alpha 4 subunit contains the principal component of the agonist binding site as well as a tryptophan residue homologous to Trp54 in alpha 7. The beta 2 subunit contains the complementary component of the agonist binding site as well as loops A and B of the principal component (Corringer et al., 1995). The homology among alpha 4, beta 2, and alpha 7 suggests that alpha alpha , beta alpha , or beta beta subunit interfaces also might form functional agonist or antagonist binding sites. The shift in agonist sensitivity seems to be specific for the alpha 4beta 2 nAChRs because it is not observed when alpha 3beta 2 and alpha 4beta 4 nAChRs are expressed at 1:1 and 1:9 alpha :beta cDNA ratios (Luetje and Patrick, 1991). This indicates that neither alpha alpha nor beta beta subunit interfaces are directly involved in the change in sensitivity to ACh.

The results show that the inhibitory effects of d-TC on alpha 4beta 2 nAChRs are not due to ion channel block. Low concentrations of d-TC have been shown to inhibit neuronal nAChRs by a competitive interaction before (Bertrand et al., 1990), but the exact nature of the inhibitory effect of the very high concentrations of d-TC on nAChRs at the 1:9 alpha :beta ratio remains to be investigated. However, the four distinct IC50 values for d-TC do not necessarily imply that alpha 4beta 2 nAChRs contain four distinct binding sites for d-TC. Apart from the component with very low sensitivity, the effects of d-TC consist of monophasic inhibition curves with shallow slopes, which gradually shift to higher concentrations with decreasing alpha :beta ratio (Fig. 3; Table 2). This indicates that high and low affinity sites differentially contribute to the inhibitory effect of d-TC and cause shift of the IC50. Three two-component inhibition curves of d-TC were simultaneously fitted to the three sets of data obtained for the 9:1, 1:1, and 1:9 (10 µM ACh) alpha :beta ratios. Hill coefficients were set to 1, and the IC50 values of d-TC and the relative proportions of the two effects of d-TC were estimated. This yielded IC50 values of 0.16 and 4.3 µM d-TC, regardless of alpha :beta ratio. The estimated proportions of the more- and less-sensitive components changed with alpha :beta ratio. The size of the more sensitive component decreased from 88% at the 9:1 alpha :beta ratio to 62% and further to 26% at the 1:1 and 1:9 alpha :beta ratios, respectively. The curves fitted according to the two-component inhibition model (Fig. 3) demonstrate that for alpha 4beta 2 nAChRs, at least two sites with an estimated 27-fold difference in sensitivity to d-TC are required to account for the inhibitory effects observed. This is in the same order of magnitude as the 15- and 27-fold differences in sensitivity of alpha 1beta 1gamma and alpha 1beta 1delta muscle-type nAChRs expressed in fibroblasts and human embryonic kidney 293 cells to d-TC and dimethyl-d-TC, respectively (Blount and Merlie, 1989; Sine, 1993). The shift in the inhibition curve of d-TC can be accounted for by assuming a minimum of two distinct sites for d-TC. The differential contribution of these sites to the inhibitory effect at different alpha :beta ratios suggests that they are located on distinct subtypes of alpha 4beta 2 nAChRs. The possibility that the high and low affinity components reflect effects of d-TC on a single population of receptors is highly unlikely. If the two sites would be present on the same nAChR, only the inhibition caused by the binding of d-TC to the high affinity site would have been detected. Some receptors seem to lack both sites because they are affected by d-TC at very high concentrations only.

The results with d-TC indicate that two subtypes of alpha 4beta 2 nAChRs may be distinguished in oocytes injected with cDNAs at the 1:1 alpha :beta ratio. In oocytes injected with cRNAs or cDNAs encoding chick alpha 4 and beta 2 subunits at a 1:1 ratio, nAChRs seem to have a 2:3 alpha :beta stoichiometry (Anand et al., 1991; Cooper et al., 1991). The current and the previous results are compatible when two subunit arrangements, which are possible for the 2:3 alpha :beta stoichiometry (Fig. 6), are formed and have distinct sensitivities to d-TC. The diverging results on the number of conductance levels of single ion channels formed by alpha 4beta 2 nAChRs at the 1:1 alpha :beta ratio provide no conclusive evidence on alpha 4beta 2 nAChR heterogeneity (Papke et al., 1989; Cooper et al., 1991; Charnet et al., 1992; Kuryatov et al., 1997). Single-channel properties of alpha 4beta 2 nAChRs at other than the 1:1 alpha :beta ratio have not been reported. Whether the arrangement of subunits within a receptor affects single-channel properties remains unknown. The current results demonstrate that changing the relative abundance of subunits expressed by changing the cDNA ratio leads to alternative subunit assemblies with sensitivities to ACh and d-TC distinct from those obtained for nAChRs at the 1:1 alpha :beta ratio.

The ratios of subunit cDNAs used in the current study for the expression of distinct subtypes of alpha 4beta 2 nAChRs in oocytes are in the same order of magnitude as those found in brain. The ratio of alpha 4:beta 2 mRNA levels in various regions of rat brain ranges between 1:1 and 1:15 (Liu et al., 1996). For alpha -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-type glutamate receptors, it has been shown that the number of glutamic acid type 2 receptor subunits incorporated depends on the relative abundance of the glutamic acid type 2 receptor subunit expressed in oocytes as well as in rat hippocampal interneurons. The resulting differences in subunit stoichiometry of native and heterologously expressed alpha -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors are associated with changes in channel function (Washburn et al., 1997). Although it was assumed previously that nAChRs have a fixed subunit stoichiometry, the current results show that alpha 4beta 2 nAChR subunit stoichiometry also can be changed by altering the relative abundance of alpha  and beta  subunits. Thus, changing the subunit stoichiometry of receptors by selective up- or down-regulation of the expression level of specific subunits seems to be a more general mechanism to tune the properties of ligand-gated ion channels. The current observation that agonist and antagonist sensitivities depend on subunit stoichiometry provides a rational basis for the existence of heteromeric neuronal nAChRs.

    Acknowledgments

We thank Dr. Jim Patrick (Baylor College of Medicine, Houston, TX) for donating the cDNA clones of nAChR subunits, Kees Koster (Hubrecht Laboratory, Utrecht, The Netherlands) for supplying X. laevis oocytes, John Rowaan for taking care of the frogs in our laboratory, and Ing. Aart de Groot for excellent technical assistance.

    Footnotes

Received May 18, 1998; Accepted September 14, 1998

This work was financially supported by Netherlands Organization for Scientific Research (NWO) Grant 903-42-011.

Send reprint requests to: Dr. R. Zwart, Research Institute of Toxicology, Utrecht University, P.O. Box 80.176, NL-3508 TD Utrecht, The Netherlands. E-mail: r.zwart{at}ritox.vet.uu.nl

    Abbreviations

nAChR, nicotinic acetylcholine receptor; ACh, acetylcholine; ANOVA, analysis of variance; d-TC, d-tubocurarine; HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid.

    References
Top
Summary
Introduction
Procedures
Results
Discussion
References


0026-895X/98/061124-08$3.00/0
MOLECULAR PHARMACOLOGY, 54:1124-1131 (1998).
Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
T. D. McClure-Begley, N. M. King, A. C. Collins, J. A. Stitzel, J. M. Wehner, and C. M. Butt
Acetylcholine-Stimulated [3H]GABA Release from Mouse Brain Synaptosomes is Modulated by {alpha}4{beta}2 and {alpha}4{alpha}5{beta}2 Nicotinic Receptor Subtypes
Mol. Pharmacol., April 1, 2009; 75(4): 918 - 926.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
N. B. Fedorov, L. C. Benson, J. Graef, P. M. Lippiello, and M. Bencherif
Differential Pharmacologies of Mecamylamine Enantiomers: Positive Allosteric Modulation and Noncompetitive Inhibition
J. Pharmacol. Exp. Ther., February 1, 2009; 328(2): 525 - 532.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
B. Lamotte d'Incamps and P. Ascher
Four Excitatory Postsynaptic Ionotropic Receptors Coactivated at the Motoneuron-Renshaw Cell Synapse
J. Neurosci., December 24, 2008; 28(52): 14121 - 14131.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Moroni, R. Vijayan, A. Carbone, R. Zwart, P. C. Biggin, and I. Bermudez
Non-Agonist-Binding Subunit Interfaces Confer Distinct Functional Signatures to the Alternate Stoichiometries of the {alpha}4{beta}2 Nicotinic Receptor: An {alpha}4-{alpha}4 Interface Is Required for Zn2+ Potentiation
J. Neurosci., July 2, 2008; 28(27): 6884 - 6894.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Gotti, M. Moretti, N. M. Meinerz, F. Clementi, A. Gaimarri, A. C. Collins, and M. J. Marks
Partial Deletion of the Nicotinic Cholinergic Receptor {alpha}4 or {beta}2 Subunit Genes Changes the Acetylcholine Sensitivity of Receptor-Mediated 86Rb+ Efflux in Cortex and Thalamus and Alters Relative Expression of {alpha}4 and {beta}2 Subunits
Mol. Pharmacol., June 1, 2008; 73(6): 1796 - 1807.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. Zwart, A. L. Carbone, M. Moroni, I. Bermudez, A. J. Mogg, E. A. Folly, L. M. Broad, A. C. Williams, D. Zhang, C. Ding, et al.
Sazetidine-A Is a Potent and Selective Agonist at Native and Recombinant {alpha}4{beta}2 Nicotinic Acetylcholine Receptors
Mol. Pharmacol., June 1, 2008; 73(6): 1838 - 1843.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
N. P. Barrera, J. Betts, H. You, R. M. Henderson, I. L. Martin, S. M. J. Dunn, and J. M. Edwardson
Atomic Force Microscopy Reveals the Stoichiometry and Subunit Arrangement of the {alpha}4{beta}3{delta} GABAA Receptor
Mol. Pharmacol., March 1, 2008; 73(3): 960 - 967.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
S. H. Hadley and J. Amin
Rat {alpha}6beta2{delta} GABAA receptors exhibit two distinct and separable agonist affinities
J. Physiol., June 15, 2007; 581(3): 1001 - 1018.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
L. Tapia, A. Kuryatov, and J. Lindstrom
Ca2+ Permeability of the ({alpha}4)3(beta2)2 Stoichiometry Greatly Exceeds That of ({alpha}4)2(beta2)3 Human Acetylcholine Receptors
Mol. Pharmacol., March 1, 2007; 71(3): 769 - 776.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. J. Marks, P. Whiteaker, and A. C. Collins
Deletion of the {alpha}7, beta2, or beta4 Nicotinic Receptor Subunit Genes Identifies Highly Expressed Subtypes with Relatively Low Affinity for [3H]Epibatidine
Mol. Pharmacol., September 1, 2006; 70(3): 947 - 959.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Moroni, R. Zwart, E. Sher, B. K. Cassels, and I. Bermudez
{alpha}4beta2 Nicotinic Receptors with High and Low Acetylcholine Sensitivity: Pharmacology, Stoichiometry, and Sensitivity to Long-Term Exposure to Nicotine
Mol. Pharmacol., August 1, 2006; 70(2): 755 - 768.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. A. Briggs, E. J. Gubbins, M. J. Marks, C. B. Putman, R. Thimmapaya, M. D. Meyer, and C. S. Surowy
Untranslated Region-Dependent Exclusive Expression of High-Sensitivity Subforms of {alpha}4beta2 and {alpha}3beta2 Nicotinic Acetylcholine Receptors
Mol. Pharmacol., July 1, 2006; 70(1): 227 - 240.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
P. J. Groot-Kormelink, S. Broadbent, M. Beato, and L. G. Sivilotti
Constraining the Expression of Nicotinic Acetylcholine Receptors by Using Pentameric Constructs
Mol. Pharmacol., February 1, 2006; 69(2): 558 - 563.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. M. White
Pretty Subunits All in a Row: Using Concatenated Subunit Constructs to Force the Expression of Receptors with Defined Subunit Stoichiometry and Spatial Arrangement
Mol. Pharmacol., February 1, 2006; 69(2): 407 - 410.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. M. Person, K. L. Bills, H. Liu, S. K. Botting, J. Lindstrom, and G. B. Wells
Extracellular Domain Nicotinic Acetylcholine Receptors Formed by {alpha}4 and {beta}2 Subunits
J. Biol. Chem., December 2, 2005; 280(48): 39990 - 40002.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
P. V. Plazas, E. Katz, M. E. Gomez-Casati, C. Bouzat, and A. B. Elgoyhen
Stoichiometry of the {alpha}9{alpha}10 Nicotinic Cholinergic Receptor
J. Neurosci., November 23, 2005; 25(47): 10905 - 10912.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
N. O. Rodrigues-Pinguet, T. J. Pinguet, A. Figl, H. A. Lester, and B. N. Cohen
Mutations Linked to Autosomal Dominant Nocturnal Frontal Lobe Epilepsy Affect Allosteric Ca2+ Activation of the {alpha}4{beta}2 Nicotinic Acetylcholine Receptor
Mol. Pharmacol., August 1, 2005; 68(2): 487 - 501.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. C. Ben-Ami, L. Yassin, H. Farah, A. Michaeli, M. Eshel, and M. Treinin
RIC-3 Affects Properties and Quantity of Nicotinic Acetylcholine Receptors via a Mechanism That Does Not Require the Coiled-coil Domains
J. Biol. Chem., July 29, 2005; 280(30): 28053 - 28060.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
B. S. Khakh, J. A. Fisher, R. Nashmi, D. N. Bowser, and H. A. Lester
An Angstrom Scale Interaction between Plasma Membrane ATP-Gated P2X2 and {alpha}4{beta}2 Nicotinic Channels Measured with Fluorescence Resonance Energy Transfer and Total Internal Reflection Fluorescence Microscopy
J. Neurosci., July 20, 2005; 25(29): 6911 - 6920.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
X.-Q. Ren, S.-B. Cheng, M. W. Treuil, J. Mukherjee, J. Rao, K. H. Braunewell, J. M. Lindstrom, and R. Anand
Structural Determinants of {alpha}4{beta}2 Nicotinic Acetylcholine Receptor Trafficking
J. Neurosci., July 13, 2005; 25(28): 6676 - 6686.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. Tsuneki, Y. You, N. Toyooka, S. Kagawa, S. Kobayashi, T. Sasaoka, H. Nemoto, I. Kimura, and J. A. Dani
Alkaloids Indolizidine 235B', Quinolizidine 1-epi-207I, and the Tricyclic 205B are Potent and Selective Noncompetitive Inhibitors of Nicotinic Acetylcholine Receptors
Mol. Pharmacol., October 1, 2004; 66(4): 1061 - 1069.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Y. Lopez-Hernandez, J. Sanchez-Padilla, A. Ortiz-Acevedo, J. Lizardi-Ortiz, J. Salas-Vincenty, L. V. Rojas, and J. A. Lasalde-Dominicci
Nicotine-induced Up-regulation and Desensitization of {alpha}4{beta}2 Neuronal Nicotinic Receptors Depend on Subunit Ratio
J. Biol. Chem., September 3, 2004; 279(36): 38007 - 38015.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
R. Nashmi, M. E. Dickinson, S. McKinney, M. Jareb, C. Labarca, S. E. Fraser, and H. A. Lester
Assembly of {alpha}4{beta}2 Nicotinic Acetylcholine Receptors Assessed with Functional Fluorescently Labeled Subunits: Effects of Localization, Trafficking, and Nicotine-Induced Upregulation in Clonal Mammalian Cells and in Cultured Midbrain Neurons
J. Neurosci., December 17, 2003; 23(37): 11554 - 11567.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
K G Paradiso and J. H. Steinbach
Nicotine is highly effective at producing desensitization of rat {alpha}4{beta}2 neuronal nicotinic receptors
J. Physiol., December 15, 2003; 553(3): 857 - 871.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Zhou, M. E. Nelson, A. Kuryatov, C. Choi, J. Cooper, and J. Lindstrom
Human {alpha}4{beta}2 Acetylcholine Receptors Formed from Linked Subunits
J. Neurosci., October 8, 2003; 23(27): 9004 - 9015.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. E. Nelson, A. Kuryatov, C. H. Choi, Y. Zhou, and J. Lindstrom
Alternate Stoichiometries of alpha 4beta 2 Nicotinic Acetylcholine Receptors
Mol. Pharmacol., February 1, 2003; 63(2): 332 - 341.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
S. S Khiroug, P. C Harkness, P. W Lamb, S. N Sudweeks, L. Khiroug, N. S Millar, and J. L Yakel
Rat nicotinic ACh receptor {alpha}7 and {beta}2 subunits co-assemble to form functional heteromeric nicotinic receptor channels
J. Physiol., April 15, 2002; 540(2): 425 - 434.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
B. Buisson and D. Bertrand
Chronic Exposure to Nicotine Upregulates the Human {alpha}4{beta}2 Nicotinic Acetylcholine Receptor Function
J. Neurosci., March 15, 2001; 21(6): 1819 - 1829.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. Figl and B. N Cohen
The {beta} subunit dominates the relaxation kinetics of heteromeric neuronal nicotinic receptors
J. Physiol., May 1, 2000; 524(3): 685 - 699.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
S. S. Khiroug, P. C. Harkness, P. W. Lamb, S. N. Sudweeks, L. Khiroug, N. S. Millar, and J. L. Yakel
Rat nicotinic ACh receptor {alpha}7 and {beta}2 subunits co-assemble to form functional heteromeric nicotinic receptor channels
J. Physiol., February 22, 2002; (2002) 200101384.
[Abstract] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zwart, R.
Right arrow Articles by Vijverberg, H. P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zwart, R.
Right arrow Articles by Vijverberg, H. P. M.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics